Welcome to ECOL - Join Free - Sign In
Albendazole CAS 54965-21-8
Albendazole CAS 54965-21-8
Supplier Info
[China Supplier]
Contact Person : Mr. Gao Xiangyang
Tel : 86-29-85733402
Fax : 86-29-85733405
Product Detail
Albendazole CAS 54965-21-8 Appearance: White crystalline powder Usage: Animal Pharmaceuticals

Albendazole, marketed as Albenza, Eskazole, Zentel, Andazol and Alworm, is a member of thebenzimidazole compounds used as a drug indicated for the treatment of a variety of worm infestations. Although this use is widespread in the United States, the U.S. Food and Drug Administration (FDA) has not approved albendazole for this indication. It is marketed by Amedra Pharmaceuticals. Albendazole was first discovered at the SmithKline Animal Health Laboratories in 1972. It is a broad spectrum anthelmintic, effective against: roundworms, tapeworms, and flukes of domestic animals and humans.

Main uses

It is effective first line of treatment against:

Flatworms Flukes/trematodes FasciolosisTapeworm/cestodes CysticercosisEchinococcosisNematodes Enterobiasis (pinworm infection)Trichuriasis (whipworm infection)AscariasisHookwormCutaneous larva migrans (caused by Ancylostoma)Filariasis

Specifications:

      

Item                  Standard                                Test Result

Appearance   White crystalline powder       Pass

Identification    Positive reaction                    Pass

Melting             206-212                                 207.2-210.2

Related Substances ≤0.5%                           Pass

Drying                  ≤0.5%                                   0.42%

Residue on Ignition≤0.2%                              0.15%

Fineness                   ≤10mesh                       pass

Assay(HPLC)  98.0%-102.0%                        99.60%

INSPECTION RESULT COMPLY WITH THE USP27

Albendazole CAS 54965-21-8

Related Products
Ads by Google

Hot Products: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
Copyright Notice @ 2008-2022 ECOL Limited and/or its subsidiaries and licensors. All rights reserved.